Your browser doesn't support javascript.
loading
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.
Abelin, Jennifer G; Harjanto, Dewi; Malloy, Matthew; Suri, Prerna; Colson, Tyler; Goulding, Scott P; Creech, Amanda L; Serrano, Lia R; Nasir, Gibran; Nasrullah, Yusuf; McGann, Christopher D; Velez, Diana; Ting, Ying S; Poran, Asaf; Rothenberg, Daniel A; Chhangawala, Sagar; Rubinsteyn, Alex; Hammerbacher, Jeff; Gaynor, Richard B; Fritsch, Edward F; Greshock, Joel; Oslund, Rob C; Barthelme, Dominik; Addona, Terri A; Arieta, Christina M; Rooney, Michael S.
  • Abelin JG; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Harjanto D; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Malloy M; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Suri P; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Colson T; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Goulding SP; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Creech AL; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Serrano LR; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Nasir G; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Nasrullah Y; Neon Therapeutics, Cambridge, MA 02139, USA.
  • McGann CD; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Velez D; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Ting YS; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Poran A; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Rothenberg DA; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Chhangawala S; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Rubinsteyn A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Hammerbacher J; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Gaynor RB; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Fritsch EF; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Greshock J; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Oslund RC; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Barthelme D; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Addona TA; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Arieta CM; Neon Therapeutics, Cambridge, MA 02139, USA.
  • Rooney MS; Neon Therapeutics, Cambridge, MA 02139, USA. Electronic address: mrooney@neontherapeutics.com.
Immunity ; 51(4): 766-779.e17, 2019 10 15.
Article en En | MEDLINE | ID: mdl-31495665
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Espectrometría de Masas / Linfocitos T CD4-Positivos / Antígenos de Histocompatibilidad Clase II / Mapeo Epitopo / Vacunas contra el Cáncer / Antígenos HLA / Inmunoterapia / Células Presentadoras de Antígenos / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Espectrometría de Masas / Linfocitos T CD4-Positivos / Antígenos de Histocompatibilidad Clase II / Mapeo Epitopo / Vacunas contra el Cáncer / Antígenos HLA / Inmunoterapia / Células Presentadoras de Antígenos / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article